A137310 Stock Overview
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
SD Biosensor, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,050.00 |
| 52 Week High | ₩34,500.00 |
| 52 Week Low | ₩9,570.00 |
| Beta | 0.82 |
| 1 Month Change | 17.22% |
| 3 Month Change | -6.52% |
| 1 Year Change | -62.34% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -80.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| A137310 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 6.4% | 0.3% | 0.5% |
| 1Y | -62.3% | 10.6% | 4.4% |
Return vs Industry: A137310 underperformed the KR Medical Equipment industry which returned 10.6% over the past year.
Return vs Market: A137310 underperformed the KR Market which returned 4.4% over the past year.
Price Volatility
| A137310 volatility | |
|---|---|
| A137310 Average Weekly Movement | 6.7% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 2.9% |
Stable Share Price: A137310 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: A137310's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 576 | Hyo Keun Lee | https://www.sdbiosensor.com |
SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters.
SD Biosensor, Inc Fundamentals Summary
| A137310 fundamental statistics | |
|---|---|
| Market Cap | ₩1.47t |
| Earnings (TTM) | -₩693.73b |
| Revenue (TTM) | ₩693.45b |
2.1x
P/S Ratio-2.1x
P/E RatioIs A137310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A137310 income statement (TTM) | |
|---|---|
| Revenue | ₩693.45b |
| Cost of Revenue | ₩696.96b |
| Gross Profit | -₩3.50b |
| Other Expenses | ₩690.22b |
| Earnings | -₩693.73b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.67k |
| Gross Margin | -0.51% |
| Net Profit Margin | -100.04% |
| Debt/Equity Ratio | 14.7% |
How did A137310 perform over the long term?
See historical performance and comparisonDividends
8.2%
Current Dividend Yield-15%
Payout RatioDoes A137310 pay a reliable dividends?
See A137310 dividend history and benchmarks| SD Biosensor dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2023 |
| Dividend Pay Date | Apr 15 2024 |
| Days until Ex dividend | 23 days |
| Days until Dividend pay date | 133 days |
Does A137310 pay a reliable dividends?
See A137310 dividend history and benchmarks